trending Market Intelligence /marketintelligence/en/news-insights/trending/8kgomjt3fdr0lkaqa1o6ya2 content esgSubNav
In This List

DigiPath regains Nev. medical marijuana licenses, resumes operations

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


DigiPath regains Nev. medical marijuana licenses, resumes operations

DigiPath Inc. said the Nevada Department of Taxation, Marijuana Enforcement Division reinstated its licenses, allowing it to resume cannabis testing operations.

The company has resumed its cannabis testing operations following the approval of its plan of correction.

The suspension of DigiPath's medical marijuana registration certificate and marijuana testing facility license was due to regulatory violations.